Why the study?
Guidelines establishing intensive medical therapy as effective as revascularization for stable ischemic heart disease are often overlooked due to enthusiasm for revascularization procedures.
Does percutaneous coronary intervention prevent cardiac events and death compared to intensive medical management in patients with stable ischemic heart disease?
Does percutaneous coronary intervention prevent cardiac events and death compared to intensive medical management in patients with stable ischemic heart disease?
Intensive medical management is as effective as revascularization for stable ischemic heart disease, reinforcing current management guidelines.
Answers are grounded in this paper and cite their sources.
Supports adherence to medical management guidelines in stable IHD; leaves open strategies to counter procedural enthusiasm.
A major outcome of cardiology research over the last 2 decades is the finding that intensive medical management of patients with stable ischemic heart disease is as effective as revascularization procedures in preventing cardiac events and death. This finding has generated management guidelines that often are overlooked because of misplaced enthusiasm for revascularization procedures.
No takes yet. Share an insight, caveat, or question.
Herbert et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: